Mutational events in LMP1 gene of epstein-barr virus in salivary gland lymphoepithelial carcinomas

International Journal of Cancer

Volumn 105, Issue 5, 2003, Pages 654-660

  Jen, Kai Yu ^a   Cheng, Jun ^a   Li, Jian ^b   Wu, Lanyan ^c   Li, Yingfang ^d   Yu, Shifeng ^e   Lin, Hanliang ^f   Chen, Zhilong ^g   Gurtsevitch, Vladimir ^h   Saku, Takashi ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c SICHUAN UNIVERSITY   (China)

^d KUNMING MEDICAL UNIVERSITY   (China)

^e PEKING UNIVERSITY   (China)

^f SUN YAT SEN UNIVERSITY   (China)

^g NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^h N N BLOKHIN RUSSIAN CANCER RESEARCH CENTER   (Russian Federation)

Author keywords

EBV; LMP1; Lymphoepithelial carcinoma; Mutation; Salivary gland

Indexed keywords

GENE PRODUCT; GENOMIC DNA; LATENT MEMBRANE PROTEIN 1; MONOCLONAL ANTIBODY; RNA; VIRUS PROTEIN;

ARTICLE; DNA SEQUENCE; EPSTEIN BARR VIRUS; GENE; GENE MUTATION; HEAD AND NECK CARCINOMA; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LMP1 GENE; LYMPHOEPITHELIOMA; MAJOR CLINICAL STUDY; NONHUMAN; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SALIVARY GLAND CARCINOMA; VIRUS CARCINOGENESIS; VIRUS DETECTION;

CARCINOMA, SQUAMOUS CELL; CHINA; CODON; DNA MUTATIONAL ANALYSIS; EPSTEIN-BARR VIRUS INFECTIONS; GENES, VIRAL; GENOME, VIRAL; HERPESVIRUS 4, HUMAN; HUMANS; MUTATION; MUTATION, MISSENSE; POINT MUTATION; POLYMERASE CHAIN REACTION; RUSSIA; SALIVARY GLAND NEOPLASMS; SEQUENCE DELETION; TAIWAN; TUMOR VIRUS INFECTIONS; VIRAL MATRIX PROTEINS; VIRAL STRUCTURAL PROTEINS;

EID: 0037499552     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.11100     Document Type: Article

References (29)

1. Niedobitek G, Hansmann ML, Herbst H, Young LS, Dienemann D, Hartmann CA, Finn T, Pitteroff S, Welt A, Anagnostopoulos I, Friedrich R, Lobeck H, et al. Epstein-Barr virus and carcinoma: undifferentiated carcinomas but not squamous cells carcinomas of the nasopharynx are regularly associated with the virus. J Pathol 1991; 165:17-24.
2. Shibata D, Tokunaga M, Uemura Y, Sato E, Tanaka S, Weiss LM, Association of Epstein-Barr virus undifferentiated gastric carcinoma with intense lymphoid infiltrate - lymphoepithelioma-like carcinoma. Am J Pathol 1991;139:469-74.
3. Pittaluga S, Wong MP, Chung LP, Loke SL. Clonal Epstein-Barr virus in lymphoepithelioma-like carcinoma of the lung. Am J Surg Pathol 1993;17:678-82.
4. Leyvraz S, Henle W, Chahinian AP, Perlmann C, Klein G, Gordon RE, Rosenblum M, Holland J. Association of Epstein-Barr virus with thymic carcinoma. N Engl J Med 1985;312:1296-9.
5. Albeck H, Nielsen NH, Hansen HE, Bentzen J, Ockelmann HH, Bretlau P, Hansen HS. Epidemiology of nasopharyngeal and salivary carcinoma in Greenland. Arctic Med Res 1992;51:189-95.
6. Albeck H, Bentzen J, Ockelmann HH, Nielsen NH, Bretlau P, Hansen HS. Familial clusters of nasopharyngeal carcinoma and salivary gland carcinomas in Greenland natives. Cancer 1993;72:196-200.
7. Leung SY, Chung LP, Yuen ST, Ho CM, Wong MP, Chan SY. Lymphoepithelial carcinoma of the salivary gland: in situ detection of Epstein-Barr virus. J Clin Pathol 1995;48:1022-27.
8. Kuo T, Hsueh C. Lymphoepithelioma-like salivary gland carcinoma in Taiwan: a clinicopathological study of nine cases demonstrating a strong association with Epstein-Barr virus. Histopathology 1997;31:75-82.
9. Chan JKC, Yip TTC, Tsang WYW, Poon YF, Wong CSC, Ma VWS. Specific association of Epstein-Barr virus with lymphoepithelial carcinoma among tumor and tumorlike lesions of the salivary gland. Arch Pathol Lab Med 1994;118:994-7.
10. Niedobitek G, Young LS. Epstein-Barr virus persistence and virus associated tumors. Lancet 1994;343:333-5.
11. Chen ML, Tsai CN, Liang CL, Shu CH, Huang CR, Sulitzeanu D, Liu ST, Chang YS. Cloning and characterization of the latent membrane protein (LMP) of a specific Epstein-Barr virus variant derived from the nasopharyngeal carcinoma in Taiwanese population. Oncogene 1992;7:2131-40.
12. Hu LF, Chen F, Zheng X, Ernberg I, Cao SL, Christensson B, Klein G, Winberg G. Clonability and tumorigenicity of human epithelial cells expressing the EBV encoded membrane protein LMP1. Oncogene 1993;8:1575-83.
13. Hu LF, Zabarovsky ER, Chen F, CAO SL, Ernberg I, Klein G, Winberg G. Isolation and sequencing of the Epstein-Barr virus BNLF-1 gene (LMP1) from a Chinese nasopharyngeal carcinoma. J Gen Virol 1991;72:2399-409.
14. Cheung ST, Lo KW, Leung SF, Chan WY, Choi PHK, Johnson PJ, Lee JCK, Huang DP. Prevalence of LMP1 deletion variant of Epstein-Barr virus in nasopharyngeal carcinoma and gastric tumors in Hong Kong. Int J Cancer 1996;66:711-2.
15. Miller WE, Edwards RH, Walling DM, Raab-Traub N. Sequence variation in the Epstein-Barr virus latent membrane protein 1. J Gen Virol 1994;75:2729-40.
16. Chen HL, Lung ML, Chan KH, Griffin BE, Ng MH. Tissue distribution of Epstein-Barr virus genotypes. J Virol 1996;70:7301-5.
17. Leung SY, Yuen ST, Chung LP, Chan SYA, Wong MP. Prevalence of mutations and 30-bp deletion in the C-terminal region of Epstein-Barr virus latent membrane protein-1 oncogene in reactive lymphoid tissue and non-nasopharyngeal EBV-associated carcinomas in Hong Kong Chinese. Int J Cancer 1997;72:225-30.
18. Legerwood EC, Pober JR, Bradley JR. Recent advances in the molecular basis of TNF signal transduction. Lab Invest 1999;79:1041-50.
19. Johnson RJ, Stack M, Hazlewood SA, Jones M, Blackmore CG, Hu LF, Rowe M. The 30-base-pair deletion in Chinese variants of the Epstein-Barr Virus LMP1 gene is not the major effector of functional differences between variant LMP1 genes in human lymphocytes. J Virol 1998;72:4038-48.
20. Saku T, Cheng J, Jen KY, Tokunaga M, Liu AR, Zhang WG, Wu LY, Lu Y, Zhou ZY, Li YF, Li R, Rao HL et al. Epstein-Barr virus infected lymphoepithelial carcinomas of the salivary gland in the Russia-Asian area: a clinicopathologic study of 160 cases. Arch Pathol 2003;47:35-40.
21. D'Addario M, Chauvin P. Ethnic differences in the expression of Epstein-Barr virus latent membrane protein-1 mutations in nasopharyngeal carcinoma. Mutat Res 2000;457:69-78.
22. Sung NS, Edwards RH, Moiseiwitsch SF, Perkins AG, Zheng Y, Raab-Traub N. Epstein-Barr virus strain variation in nasopharyngeal carcinoma from the endemic and non-endemic regions of China. Int J Cancer 1998;76:207-15.
23. Cheung ST, Leung SF, Lo KW, Chiu KW, Tam JSL, Fok TF, Johnson PJ, Lee JCK, Huang DP. Specific latent membrane protein 1 gene sequences in type 1 and type 2 Epstein-Barr virus from nasopharyngeal carcinoma in Hong Kong. Int J Cancer 1998;76:399-406.
24. Zhang XS, Song KH, Mai HQ, Jia WH, Feng BJ, Xia JC, Zhang RH, Huang LX, Yu XJ, Feng QS, Huang P, Yu XJ. The 30-bp deletion variant: a polymorphism of latent membrane protein 1 prevalent in endemic and no-endemic areas of nasopharyngeal carcinomas in China. Cancer Lett 2002;176:65-73.
25. Hahn P, Novikova E, Scherback L, Janik C, Pavlish O, Arkhipov V, Nicholls J, Müller-Lantzsch N, Gurtsevitch V, Grässer FA. The LMP1 gene isolated from Russian nasopharyngeal carcinoma has no 30-bp deletion. Int J Cancer 2001;91:815-21.
26. Huen DS, Henderson SA, Croom-Carter D, Rowe M. The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NFκB and cell surface phenotype via 2 effector regions in its carboxy-terminal cytoplasmic domain. Oncogene 1995;10:549-60.
27. Blake SMS, Eliopoulos AG, Dawson CW and Young LS. The transmembrane domains of the EBV-encoded latent membrane protein 1 (LMP1) variant CAO regulate signaling activity. Virology 2001;282:278-87.
28. Liao W, Tang M, Yin L. EBV latent membrane protein 1 induces p53 expression via NF-kappa B in nasopharyngeal carcinoma. Zhonghua Zhong Liu Za Zhi 2001;23:199-201.
29. Kirch HC, Flaswinkel S, Rumpf H, Brockmann, Esche H. Expression of human p53 requires synergistic activation of transcription from the p53 promoter by AP-1, NFκB and Myc/Max. Oncogene 1999;18:2728-38.